Tag: ProMIS

July 3, 2018

4 Top Biotech Stocks on the TSX of Q2 2018

Which biotech stocks on the TSX have performed the best year-to-date? These four companies have risen to the top of...
January 23, 2018

ProMIS Neurosciences Lead Product Candidate for Alzheimer’s Disease Shows Potential for Improved Therapeutic Potency

ProMIS Neurosciences (TSX:PMN) a biotechnology company focused on the discovery and development of precision treatments for neurodegenerative diseases, announced further...
October 26, 2017

The State of Novel Alzheimer's Treatments

Alzheimer's already affects nearly five million Americans, with a growing population incoming, the need for an improved treatment is a...
October 17, 2017

ProMIS' Updates Effectiveness of Lead Product Against Alzheimer's

ProMIS Neurosciences provided an update from a preclinical study comparing PMN310 to other amyloid beta-directed antibodies combating Alzheimer's disease.
September 19, 2017

5 Top Biotech Stocks on the TSX of Q3 2017

The biotech sector has steadily enjoyed an increase this year, in part thanks to significant advancements and in spite of...
August 29, 2017

5 Biotech Stocks on the TSX

Here, the Investing News Network looks at publicly traded biotech companies listed on the TSX.
August 11, 2017

ProMIS Released Its Financial Results for Q2 2017

ProMIS Neurosciences shared its financial and operational results for the second quarter of 2017.